Copyright
©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 643-653
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.643
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.643
Table 1 Domain boundaries and score for each of the domains
Source | Domain | Start | End | Gathering threshold (bits) | Score (bits) | E-value | |||
Sequence | Domain | Sequence | Domain | Sequence | Domain | ||||
Pfam | ObR_Ig | 126 | 233 | 25.8 | 25.8 | 170.5 | 61.1 | 3.50E-47 | 3.9E-13 |
Pfam | Lep_receptor_Ig | 329 | 420 | 28.8 | 28.8 | 84.8 | 84.8 | 1.00E-20 | 1.00E-20 |
Pfam | ObR_Ig | 431 | 533 | 25.8 | 25.8 | 170.5 | 112.7 | 3.50E-47 | 3.40E-29 |
Transmembrane | NA | 840 | 862 | NA | NA | NA | NA | NA | NA |
Low_complexity | NA | 849 | 863 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 924 | 927 | NA | NA | NA | NA | NA | NA |
Low_complexity | NA | 937 | 946 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 966 | 967 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 970 | 973 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 975 | 976 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 997 | 1001 | NA | NA | NA | NA | NA | NA |
Disorder | NA | 1064 | 1065 | NA | NA | NA | NA | NA | NA |
Table 2 Baseline characteristics
Control, n = 908 | HTN, n = 1061 | HTN with T2DM, n = 683 | P value | ||||
Control vs HTN | Control vs HTN + T2DM | HTN vs HTN + T2DM | |||||
Ethnic | Han | 455 | 406 | 486 | < 0.0001 | < 0.0001 | < 0.0001 |
Mongolian | 453 | 655 | 197 | ||||
Gender | Male | 357 | 601 | 397 | < 0.0001 | < 0.0001 | 0.542 |
Female | 551 | 460 | 286 | ||||
Age | 48.11 ± 15.06 | 54.49 ± 15.67 | 63.89 ± 11.17 | < 0.0001 | < 0.0001 | < 0.0001 | |
Weight (kg) | 66.14 ± 11.06 | 72.32 ± 12.06 | 73.35 ± 12.48 | < 0.0001 | < 0.0001 | 0.2156 | |
Height (cm) | 163 ± 0.09 | 168 ± 0.08 | 161.26 ± 0.10 | < 0.0001 | 0.6110 | 0.0032 | |
BMI (kg/m2) | 25.27 ± 8.50 | 25.56 ± 3.63 | 26.48 ± 5.12 | 0.4067 | 0.7588 | 0.8723 | |
FBS (mmol/L) | 5.06 ± 0.49 | 5.73 ± 0.77 | 8.59 ± 3.37 | 0.0721 | < 0.0001 | < 0.0001 | |
SBP (mm Hg) | 117.21 ± 14.27 | 151.10 ± 18.94 | 166.47 ± 17.53 | < 0.0001 | < 0.0001 | < 0.0001 | |
DBP (mm Hg) | 77.20 ± 7.95 | 88.59 ± 12.74 | 100.84 ± 13.31 | < 0.0001 | < 0.0001 | < 0.0001 | |
TG (mmol/L) | 1.63 ± 1.06 | 2.24 ± 1.52 | 2.59 ± 12.14 | 0.0626 | 0.0051 | 0.4768 | |
CHO (mmol/L) | 4.53 ± 1.30 | 4.47 ± 3.59 | 4.52 ± 1.26 | 0.8913 | 0.9984 | 0.8885 | |
HDL (mmol/L) | 1.44 ± 0.54 | 1.75 ± 0.95 | 1.27 ± 0.35 | < 0.0001 | < 0.0001 | < 0.0001 | |
LDL (mmol/L) | 2.84 ± 1.00 | 2.87 ± 1.38 | 2.94 ± 11.1 | 0.9921 | 0.9225 | 0.9586 |
Table 3 Hardy Weinberg equilibrium analysis
Group | G/G | G/A | A/A | G | A | P value | |
Han, n = 1347 | Control, n = 455 | 351 | 94 | 10 | 796 | 114 | 0.2 |
HTN, n = 406 | 312 | 91 | 3 | 715 | 97 | 0.24 | |
HTN + T2DM, n = 486 | 394 | 84 | 8 | 872 | 100 | 0.21 | |
Mongolian, n = 1305 | Control, n = 453 | 343 | 101 | 9 | 787 | 119 | 0.68 |
HTN, n = 655 | 436 | 202 | 17 | 1074 | 236 | 0.29 | |
HTN + T2DM, n = 197 | 151 | 42 | 4 | 344 | 50 | 0.53 |
Table 4 Statistics of allele and genotype frequencies
Population | Allele | All subjects count (%) | Control count (%) | HTN count (%) | HTN + T2DM count (%) | P value |
Han, n = 1347 | G | 2383 (88) | 796 (87) | 715 (88) | 872 (90) | 0.288 |
A | 311 (12) | 114 (13) | 97 (12) | 100 (10) | ||
A/A | 21 (2) | 10 (2) | 3 (1) | 8 (2) | 0.153 | |
G/A | 269 (20) | 94 (21) | 91 (22) | 84 (17) | ||
G/G | 1057 (78) | 351 (77) | 312 (77) | 394 (81) | ||
Mongolian, n = 1305 | G | 2205 (84) | 787 (87) | 1074 (82) | 344 (87) | 0.002 |
A | 405 (16) | 119 (13) | 236 (18) | 50 (13) | ||
A/A | 30 (2) | 9 (2) | 17 (3) | 4 (2) | 0.006 | |
G/A | 345 (26) | 101 (22) | 202 (31) | 42 (21) | ||
G/G | 930 (71) | 343 (76) | 436 (67) | 151 (77) |
Table 5 Association of the control and hypertension groups for Han and Mongolian Chinese
Model | Genotype | Han, n = 861 | Mongolian, n = 1108 | ||||||
Control, n (%) | HTN, n (%) | OR (95%CI) | P value | Control, n (%) | HTN, n (%) | OR (95%CI) | P value | ||
Co-dominant | G/G | 351 (77.1) | 312 (76.8) | 1 | 0.041 | 343 (75.7) | 436 (66.6) | 1 | 0.016 |
A/G | 94 (20.7) | 91 (22.4) | 0.88 (0.62-1.27) | 101 (22.3) | 202 (30.8) | 1.49 (1.12-1.97) | |||
A/A | 10 (2.2) | 3 (0.7) | 0.21 (0.05-0.80) | 9 (2.0) | 17 (2.6) | 1.47 (0.64-3.34) | |||
Dominant | G/G | 351 (77.1) | 312 (76.8) | 1 | 0.23 | 343 (75.7) | 436 (66.6) | 1 | 0.004 |
A/G-A/A | 104 (22.9) | 94 (23.1) | 0.81 (0.57-1.15) | 110 (24.3) | 219 (33.4) | 1.49 (1.13-1.95) | |||
Recessive | G/G-A/G | 445 (97.8) | 403 (99.3) | 1 | 0.015 | 444 (98) | 638 (97.4) | 1 | 0.51 |
A/A | 10 (2.2) | 3 (0.7) | 0.21 (0.05-0.82) | 9 (2.0) | 17 (2.6) | 1.32 (0.58-2.99) | |||
Over-dominant | G/G-A/A | 361 (79.3) | 315 (77.6) | 1 | 0.63 | 352 (77.7) | 453 (69.2) | 1 | 0.0064 |
A/G | 94 (20.7) | 91 (22.4) | 0.91 (0.64-1.31) | 101 (22.3) | 202 (30.8) | 1.47 (1.11-1.95) | |||
Log-additive | - | - | - | 0.75 (0.55-1.04) | 0.082 | - | - | 1.40 (1.10-1.79) | 0.0059 |
Table 6 Association of rs1137101 with hypertension + type 2 diabetes mellitus (control vs hypertension + type 2 diabetes mellitus)
Model | Genotype | Han, n = 941 | Mongolian, n = 650 | ||||||
Control, n (%) | HTN with T2DM, n (%) | OR (95%CI) | P value | Control, n (%) | HTN with T2DM, n (%) | OR (95%CI) | P value | ||
Co-dominant | G/G | 351 (77.1) | 394 (81.1) | 1 | 0.0075 | 343 (75.7) | 151 (76.7) | 1 | 0.3 |
A/G | 94 (20.7) | 84 (17.3) | 0.59 (0.40-0.87) | 101 (22.3) | 42 (21.3) | 0.70 (0.44-1.11) | |||
A/A | 10 (2.2) | 8 (1.6) | 0.38 (0.14-1.08) | 9 (2.0) | 4 (2.0) | 1.06 (0.27-4.25) | |||
Dominant | G/G | 351 (77.1) | 394 (81.1) | 1 | 0.0024 | 343 (75.7) | 151 (76.7) | 1 | 0.15 |
A/G-A/A | 104 (22.9) | 92 (18.9) | 0.56 (0.39-0.82) | 110 (24.3) | 46 (23.4) | 0.72 (0.46-1.13) | |||
Recessive | G/G-A/G | 445 (97.8) | 478 (98.3) | 1 | 0.11 | 444 (98.0) | 193 (98.0) | 1 | 0.84 |
A/A | 10 (2.2) | 8 (1.6) | 0.43 (0.15-1.21) | 9 (2.0) | 4 (2.0) | 1.15 (0.29-4.57) | |||
Over-dominant | G/G-A/A | 361 (79.3) | 402 (82.7) | 1 | 0.01 | 352 (77.7) | 155 (78.7) | 1 | 0.12 |
A/G | 94 (20.7) | 84 (17.3) | 0.61 (0.41-0.89) | 101 (22.3) | 42 (21.3) | 0.70 (0.44-1.11) | |||
Log-additive | - | - | - | 0.60 (0.43-0.83) | 0.0018 | - | - | 0.78 (0.52-1.16) | 0.22 |
Table 7 Association of rs1137101 with hypertension and type 2 diabetes mellitus (hypertension and hypertension + type 2 diabetes mellitus)
Model | Genotype | Han, n = 892 | Mongolian, n = 852 | ||||||
Control, n (%) | HTN with T2DM, n (%) | OR (95%CI) | P value | Control, n (%) | HTN with T2DM, n (%) | OR (95%CI) | P value | ||
Co-dominant | G/G | 312 (76.8) | 394 (81.1) | 1 | 0.034 | 436 (66.6) | 151 (76.7) | 1 | 0.0067 |
A/G | 91 (22.4) | 84 (17.3) | 0.65 (0.46-0.92) | 202 (30.8) | 42 (21.3) | 0.54 (0.36-0.81) | |||
A/A | 3 (0.7) | 8 (1.6) | 1.61 (0.41-6.28) | 17 (2.6) | 4 (2.0) | 0.55 (0.17-1.79) | |||
Dominant | G/G | 312 (76.8) | 394 (81.1) | 1 | 0.026 | 436 (66.6) | 151 (76.7) | 1 | 0.0016 |
A/G-A/A | 94 (23.1) | 92 (18.9) | 0.68 (0.49-0.96) | 219 (33.4) | 46 (23.4) | 0.54 (0.36-0.80) | |||
Recessive | G/G-A/G | 403 (99.3) | 478 (98.3) | 1 | 0.39 | 638 (97.4) | 193 (98.0) | 1 | 0.46 |
A/A | 3 (0.7) | 8 (1.6) | 1.77 (0.46-6.87) | 17 (2.6) | 4 (2.0) | 0.65 (0.20-2.11) | |||
Over-dominant | G/G-A/A | 315 (77.6) | 402 (82.7) | 1 | 0.012 | 453 (69.2) | 155 (78.7) | 1 | 0.0028 |
A/G | 91 (22.4) | 84 (17.3) | 0.65 (0.46-0.91) | 202 (30.8) | 42 (21.3) | 0.55 (0.37-0.82) | |||
Log-additive | - | - | - | 0.75 (0.55-1.02) | 0.067 | - | - | 0.59 (0.41-0.84) | 0.0024 |
- Citation: Zhao KY, Yuan ML, Wu YN, Cui HW, Han WY, Wang J, Su XL. Association of rs1137101 with hypertension and type 2 diabetes mellitus of Mongolian and Han Chinese. World J Diabetes 2022; 13(8): 643-653
- URL: https://www.wjgnet.com/1948-9358/full/v13/i8/643.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i8.643